TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,481 | -85.6% | 11,482 | -83.0% | 0.02% | -85.3% |
| Q2 2023 | $1,659,100 | -42.8% | 67,608 | -5.3% | 0.11% | -46.8% |
| Q1 2023 | $2,898,904 | -10.8% | 71,384 | -1.3% | 0.20% | -12.0% |
| Q4 2022 | $3,250,020 | +33.3% | 72,303 | +75.5% | 0.23% | +4.0% |
| Q2 2022 | $2,438,000 | +276.8% | 41,197 | +640.4% | 0.22% | +300.0% |
| Q1 2022 | $647,000 | +786.3% | 5,564 | +1047.2% | 0.06% | +833.3% |
| Q4 2021 | $73,000 | -96.0% | 485 | -97.5% | 0.01% | -96.9% |
| Q4 2020 | $1,833,000 | +529.9% | 19,164 | +645.7% | 0.19% | +478.8% |
| Q3 2020 | $291,000 | +94.0% | 2,570 | +10.2% | 0.03% | -66.3% |
| Q1 2020 | $150,000 | -64.9% | 2,333 | -67.5% | 0.10% | +133.3% |
| Q4 2019 | $427,000 | -77.4% | 7,168 | -75.5% | 0.04% | -77.8% |
| Q2 2019 | $1,891,000 | +4627.5% | 29,310 | +4545.0% | 0.19% | +4625.0% |
| Q1 2019 | $40,000 | – | 631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |